Skip to main content
BDX
NYSE Industrial Applications And Services

Becton Dickinson Reorganizes Business Segments, Recasts Historical Revenues

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$204.08
Mkt Cap
$58.836B
52W Low
$162.29
52W High
$245.227
52W Position info
26% above low
Off High info
17% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

BDX sits 26% above its 52-week low of $162.29.

Summary

Becton Dickinson & Co. announced a reorganization of its business segments into five new units, effective October 1, 2025, and provided recast historical financial data to reflect this new reporting structure.


Key Events · Corporate Governance and Compliance · BDX

  • Historical Revenues Recast

    The company provided recast historical segment revenues for fiscal year 2025 and prior periods, enabling investors to analyze financial performance under the new reporting framework.

  • Life Sciences Divestiture Context

    The filing reiterates the planned elimination of the Life Sciences segment following a definitive agreement (July 13, 2025) to combine its Biosciences and Diagnostic Solutions business with Waters Corporation, detailing the financial impact on future reporting.


Analysis · BDX · Industrial Applications And Services

This 8-K is important for investors as it provides the financial framework for Becton Dickinson's newly reorganized business segments, effective October 1, 2025. The company has furnished recast historical revenues for fiscal year 2025 and prior periods, which is essential for analysts to update their financial models and assess performance under the new structure. This transparency helps clarify the company's strategic direction, especially in light of the planned divestiture of the Life Sciences segment, which will further streamline its reporting into four core segments.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 29.9% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDX was trading at $204.08 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $58.8B. The 52-week trading range was $162.29 to $245.23. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Aug 06, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $177.07
Real-time Price: $178.07 info
Change: +$1.00 (+0.56%) info
Market Cap: $48.504B info
BDX
Aug 06, 2026, 6:51 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $178.07 info
Change: +$6.07 (+4%) info
Market Cap: $48.504B info
BDX
Aug 06, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $172.00
Real-time Price: $178.07 info
Change: +$6.07 (+4%) info
Market Cap: $48.504B info
BDX
Jul 31, 2026, 2:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.42
Real-time Price: $178.07 info
Change: +$12.66 (+8%) info
Market Cap: $48.504B info
BDX
Jul 29, 2026, 6:54 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $161.25
Real-time Price: $178.07 info
Change: +$16.82 (+10%) info
Market Cap: $48.504B info